These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9808403)

  • 1. Vascular endothelial growth factor in patients with rheumatoid arthritis.
    Harada M; Mitsuyama K; Yoshida H; Sakisaka S; Taniguchi E; Kawaguchi T; Ariyoshi M; Saiki T; Sakamoto M; Nagata K; Sata M; Matsuo K; Tanikawa K
    Scand J Rheumatol; 1998; 27(5):377-80. PubMed ID: 9808403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
    Ballara S; Taylor PC; Reusch P; Marmé D; Feldmann M; Maini RN; Paleolog EM
    Arthritis Rheum; 2001 Sep; 44(9):2055-64. PubMed ID: 11592367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity.
    Sone H; Sakauchi M; Takahashi A; Suzuki H; Inoue N; Iida K; Shimano H; Toyoshima H; Kawakami Y; Okuda Y; Matsuo K; Yamada N
    Life Sci; 2001 Sep; 69(16):1861-9. PubMed ID: 11693266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Ann Rheum Dis; 2002 Sep; 61(9):804-9. PubMed ID: 12176805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis.
    Lee SS; Joo YS; Kim WU; Min DJ; Min JK; Park SH; Cho CS; Kim HY
    Clin Exp Rheumatol; 2001; 19(3):321-4. PubMed ID: 11407088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of vascular endothelial growth factor in collagen diseases.
    Kikuchi K; Kubo M; Kadono T; Yazawa N; IHN H; Tamaki K
    Br J Dermatol; 1998 Dec; 139(6):1049-51. PubMed ID: 9990370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum vascular endothelial growth factor in late rheumatoid arthritis.
    Pinheiro GR; Andrade CA; Gayer CR; Coelho MS; Freire SM; Scheinberg MA
    Clin Exp Rheumatol; 2001; 19(6):721-3. PubMed ID: 11791646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.
    Ribbens C; Martin y Porras M; Franchimont N; Kaiser MJ; Jaspar JM; Damas P; Houssiau FA; Malaise MG
    Ann Rheum Dis; 2002 Feb; 61(2):161-6. PubMed ID: 11796404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis.
    Nagashima M; Wauke K; Hirano D; Ishigami S; Aono H; Takai M; Sasano M; Yoshino S
    Rheumatology (Oxford); 2000 Nov; 39(11):1255-62. PubMed ID: 11085806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies.
    Drouart M; Saas P; Billot M; Cedoz JP; Tiberghien P; Wendling D; Toussirot E
    Clin Exp Immunol; 2003 Apr; 132(1):158-62. PubMed ID: 12653851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
    Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
    Nagashima M; Asano G; Yoshino S
    J Rheumatol; 2000 Oct; 27(10):2339-42. PubMed ID: 11036826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
    Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN
    Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Lupus; 2002; 11(6):348-55. PubMed ID: 12139372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
    Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
    Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis.
    Maeno N; Takei S; Imanaka H; Takasaki I; Kitajima I; Maruyama I; Matsuo K; Miyata K
    J Rheumatol; 1999 Oct; 26(10):2244-8. PubMed ID: 10529148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated vascular endothelial growth factor in systemic sclerosis.
    Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
    J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hyaluronic acid in patients with rheumatoid arthritis, systemic sclerosis and systemic lupus erythematosus.
    Cylwik B; Gruszewska E; Gindzienska-Sieskiewicz E; Kowal-Bielecka O; Chrostek L
    Biochem Med (Zagreb); 2021 Jun; 31(2):020701. PubMed ID: 33927551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis.
    Giatromanolaki A; Sivridis E; Athanassou N; Zois E; Thorpe PE; Brekken RA; Gatter KC; Harris AL; Koukourakis IM; Koukourakis MI
    J Pathol; 2001 May; 194(1):101-8. PubMed ID: 11329148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.